Diana-Maria Bunu

Diana-Maria Bunu

Auto-generated profile, based on publicly available information

Diana-Maria Bunu

Department of Cardiology, Institute of Cardiovascular Diseases, Timisoara 300310, Romania

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2019 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
DBDiana-Maria Bunu
Diana-Maria Bunu
CTCristian-Eugen Timofte
Cristian-Eugen Timofte
Manuela CiocoiuManuela Ciocoiu
Manuela Ciocoiu
Mariana FloriaMariana Floria
Mariana Floria
CTClaudia-Cristina Tarniceriu
Claudia-Cristina Tarniceriu
DANIELA MARIA TANASEDANIELA MARIA TANASE
DANIELA MARIA TANASE
Inflammatory bowel disease (IBD) refers to a group of chronic inflammatory diseases that targets mainly the gastrointestinal tract. The clinical presentation of IBD includes both gastrointestinal manifestations and extraintestinal manifestations (EIM). The reported cardiovascular manifestations in IBD patients include pericarditis, myocarditis, venous and arterial thromboembolism, arrhythmias, atrioventricular block, heart failure, endocarditis, valvulopathies, and Takayasu arteritis. The aim of this article is to review the available literature about the possible pathogenic mechanisms and determine preventive measures capable of reducing the incidence and severity of the cardiovascular manifestations. In IBD patients, the incidence of cardiovascular manifestations is low, but higher than that in the general population. Therefore, clinicians should pay attention to any new modification that might indicate cardiovascular involvement in IBD patients, and they should consider chronic inflammatory diseases in patients with cardiac conditions without an evident cause. Considering the role of inflammation in the development of cardiovascular manifestations, the management should include prevention of flares and maintenance of remission for as long as possible. Preventive measures should also include active screening and strict control of the cardiovascular risk factors in all IBD patients.